ImmunityBio Competitors and Similar CompaniesClear all
ImmunityBio's competitors and similar companies include MABION, Sonnet BioTherapeutics, Forbius and Cugene.
 ImmunityBio ImmunityBio (formerly known as NantKwest) is a clinical-stage immunotherapy company focused on harnessing the power of the immune system using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. |  MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. |  Sonnet BioTherapeutics Sonnet BioTherapeutics (formerly known as Chanticleer Holdings) is an oncology-focused biotechnology company. |  Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. |  Cugene Cugene is a company dedicated to the discovery and development of medicines for treating cancer and inflammatory disorders. | |
Founding Date | Founding Date 2014 | Founding Date 2007 | Founding Date 2011 | Founding Date 2011 | Founding Date N/A |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Culver City, US HQ San Diego, US Woburn, US | Locations Konstantynów Łódzki, PL HQ | Locations Princeton, US HQ | Locations Austin, US HQ Montréal, CA | Locations Waltham, US HQ |
Employees | Employees 16116% increase | Employees 95 | Employees 12 | Employees 811% decrease | Employees 15 |
Valuation ($) | Valuation ($) 4.3 b | Valuation ($) 21.7 m | Valuation ($) 2.9 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $113.3m (FY, 2025) | Revenue (est.) zł15.8m (FY, 2025) | Revenue (est.) $1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $753k (FY, 2025) | Cost of goods zł24.1m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $112.5m (FY, 2025) | Gross profit (zł7.2m) (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ($351.5m) (FY, 2025) | Net income (zł62.6m) (FY, 2025) | Net income ($16m) (FY, 2025) | Net income N/A | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
MABION
HQ
Konstantynów Łódzki, PL
Employees
95
Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases.
View companySonnet BioTherapeutics
HQ
Princeton, US
Employees
12
Sonnet BioTherapeutics (formerly known as Chanticleer Holdings) is an oncology-focused biotechnology company.
View companyForbius
HQ
Austin, US
Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.
View companyCugene
HQ
Waltham, US
Employees
15
Cugene is a company dedicated to the discovery and development of medicines for treating cancer and inflammatory disorders.
View company